Showing posts with label eltrombopag. Show all posts
Showing posts with label eltrombopag. Show all posts

Thursday 28 August 2014

GSK receives FDA approval for Promacta

paolo-cropped
Dr Paolo Paoletti, president, Oncology, GSK


GlaxoSmithKline (GSK) announced that the USFDA has approved a supplemental New Drug Application (sNDA) for the once-daily use of Promacta (eltrombopag) in patients with severe aplastic anaemia (SAA), who have had an insufficient response to immunosuppressive -